Legal & General Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
35,426
+7,832
| +28% | +$317K | ﹤0.01% | 2106 |
|
|
2025
Q1 | $1.42M | Buy |
27,594
+999
| +4% | +$51.3K | ﹤0.01% | 2056 |
|
|
2024
Q4 | $1.47M | Buy |
26,595
+2,016
| +8% | +$112K | ﹤0.01% | 2107 |
|
|
2024
Q3 | $808K | Buy |
24,579
+93
| +0.4% | +$3.06K | ﹤0.01% | 2303 |
|
|
2024
Q2 | $666K | Buy |
24,486
+1,655
| +7% | +$45K | ﹤0.01% | 2328 |
|
|
2024
Q1 | $830K | Hold |
22,831
| – | – | ﹤0.01% | 2256 |
|
|
2023
Q4 | $462K | Buy |
22,831
+2,279
| +11% | +$46.2K | ﹤0.01% | 2487 |
|
|
2023
Q3 | $365K | Buy |
20,552
+7,471
| +57% | +$133K | ﹤0.01% | 2553 |
|
|
2023
Q2 | $236K | Buy |
13,081
+5,736
| +78% | +$104K | ﹤0.01% | 2701 |
|
|
2023
Q1 | $92.3K | Buy |
7,345
+442
| +6% | +$5.56K | ﹤0.01% | 2789 |
|
|
2022
Q4 | $101K | Buy |
6,903
+4,463
| +183% | +$65.4K | ﹤0.01% | 2815 |
|
|
2022
Q3 | $41K | Buy |
2,440
+909
| +59% | +$15.3K | ﹤0.01% | 3020 |
|
|
2022
Q2 | $22K | Buy |
1,531
+663
| +76% | +$9.53K | ﹤0.01% | 3205 |
|
|
2022
Q1 | $15K | Buy |
868
+50
| +6% | +$864 | ﹤0.01% | 3304 |
|
|
2021
Q4 | $19K | Hold |
818
| – | – | ﹤0.01% | 3295 |
|
|
2021
Q3 | $18K | Hold |
818
| – | – | ﹤0.01% | 3312 |
|
|
2021
Q2 | $24K | Buy |
818
+179
| +28% | +$5.25K | ﹤0.01% | 3234 |
|
|
2021
Q1 | $21K | Hold |
639
| – | – | ﹤0.01% | 3118 |
|
|
2020
Q4 | $27K | Buy |
+639
| New | +$27K | ﹤0.01% | 2981 |
|